- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 20.02. | Cereno Scientific - CMD reaffirms shifting focus to clinical delivery | 314 | Cereno Scientific's recent capital markets day (CMD) centered on CS1's progression from early clinical validation into Phase IIb development, a key inflection for the investment thesis. Supported by... ► Artikel lesen | ||
| 20.02. | Herantis Pharma - Funding to support HER-096 in Phase II | 489 | Herantis Pharma has made tangible progress towards raising funds to support its Phase II proof-of-concept study for lead asset HER-096 as a potential disease-modifier for Parkinson's disease (PD). In... ► Artikel lesen | ||
| 19.02. | Tradedoubler - Balancing growth and profitability | 262 | Tradedoubler reported FY25 revenue growth of 5% (8% in constant currency), with another year of modest growth from Partner Marketing (+3%) boosted by strong growth from Influencer Marketing (+32%).... ► Artikel lesen | ||
| 19.02. | Dentsu Group - New CEO to drive transformation | 346 | Dentsu Group's underlying FY25 results were ahead of guidance that was upgraded with the Q325 results. However, there was also less positive news. First, a further write-down of the goodwill of the... ► Artikel lesen | ||
| 18.02. | VinFast Auto - Notes from Hanoi and Hai Phong site visit | 400 | In early February Edison met the VinFast team in Hanoi, Vietnam. The primary purpose of the visit was to tour the company's main manufacturing facility in Hai Phong, about a two-hour drive from Hanoi.... ► Artikel lesen | ||
| 18.02. | Molten Ventures - Strength through diversification | 282 | Molten Ventures' recent investor day was an opportunity for the company to report on its strategic development and to feature a diverse set of portfolio companies. The CEO highlighted progress across... ► Artikel lesen | ||
| 18.02. | Thrive Renewables - Bond offer to fund next phase of UK wind build-out | 334 | Thrive Renewables launched its 2026 bond offer on 11 February 2026, targeting up to £10m, split into two offers of up to £5m each. The first offer is aimed at retail investors (minimum investment of... ► Artikel lesen | ||
| 18.02. | Borussia Dortmund - Nicely positioned for second half of the season | 390 | Borussia Dortmund's first team enters the second half of the season in a much stronger position than at this time last season, certainly from the perspective of the Bundesliga, when the team clinched... ► Artikel lesen | ||
| 17.02. | Newron Pharmaceuticals - €38m raise to support ENIGMA-TRS | 365 | Newron Pharmaceuticals has announced an equity issuance of up to €38m with a group of existing and new shareholders from Europe and Asia. Proceeds will be used to support the company's Phase III ENIGMA-TRS... ► Artikel lesen | ||
| 17.02. | Theon International - Positive results and forward momentum | 400 | Theon has reported strong FY25 growth and a continuation of mid-twenties margins, highlighting the strength of the company's night vision product offering and market position. FY26 is set for further... ► Artikel lesen | ||
| 16.02. | VEON - Invest in Ukraine event: Open for business | 2.630 | VEON's 'Invest in Ukraine' event in Dubai on 2 February focused on how Ukraine's economy and corporate sector have continued to operate, adapt and create value during the conflict, underpinned by the... ► Artikel lesen | ||
| 13.02. | Mendus - Vididencel set for a defining year | 326 | Mendus's FY25 results mark a strategically important year, culminating in the repositioning of lead asset vididencel in Q425. Clinical updates in acute myeloid leukaemia (AML) and ovarian cancer (OC)... ► Artikel lesen | ||
| 13.02. | MCB Group - equity proposition (Video) | 184 | MCB Group, headquartered in Mauritius and listed on the Stock Exchange of Mauritius, is one of Africa's largest and most diversified financial services institutions. With assets exceeding £16bn, the... ► Artikel lesen | ||
| 12.02. | Altron - Strong earnings growth in FY26 | 312 | Altron's FY26 trading update confirms that headline EPS (HEPS) and reported EPS will be significantly ahead of FY25, with continuing operations at least 30% higher and the group at least 50% higher.... ► Artikel lesen | ||
| 12.02. | Filtronic - Exploiting the growing addressable market | 381 | Filtronic's H126 results reflected stable revenues and the ongoing investment in manufacturing, engineering and business development. The company has started H226 with a record order book and efforts... ► Artikel lesen | ||
| 11.02. | MCB Group - One of Africa's most disciplined banking groups | 267 | MCB Group Ltd (MCBG) is the leading financial services group in Mauritius and a pan-African player. The group launched its Vision 2030 strategy in 2025, which sets out the goals and objectives for the... ► Artikel lesen | ||
| 11.02. | bp - Q425 results: In line, balance sheet strengthening | 393 | bp reported Q425 underlying replacement cost (RC) profit of $1.5bn (Q325: $2.2bn), broadly in line with expectations. Operating cash flow was $7.6bn, including a working capital release of $0.9bn. Net... ► Artikel lesen | ||
| 11.02. | Alkane Resources - Material EPS upgrade | 334 | Alkane's Q226 quarterly activities report revealed record quarterly gold production of 43,663oz AuE (174,652oz pa annualised cf FY26 guidance of 160-175koz) at an all-in sustaining cost (AISC) of A$2... ► Artikel lesen | ||
| 11.02. | Zinc Media - Forging market share | 343 | Zinc Media's FY25 trading update shows a strong year of progress, with both revenue and adjusted EBITDA increasing by c 27%. Management believes its progress across its three strategic growth pillars... ► Artikel lesen | ||
| 10.02. | HgT - SaaS is not dead | 280 | HgT reported its full-year trading update, posting a 4.0% NAV total return (TR) in FY25, bringing its five- and 10-year NAV TR to 14.1% and 17.0% per year, respectively. The FY25 return was driven by... ► Artikel lesen | ||
| 10.02. | BioVersys - Poised to unlock value in critical AMR | 384 | BioVersys is focused on developing novel drugs to address antimicrobial resistance (AMR). Lead asset BV100 is targeting carbapenem-resistant Acinetobacter baumannii (CRAB) infections, a significant... ► Artikel lesen | ||
| 10.02. | S&U - Robust delivery through FY26 | 274 | S&U published an update on trading to 5 February (end-FY26) and will release its annual results on 21 April. Group performance continues to be characterised by robust growth in the property lending... ► Artikel lesen | ||
| 10.02. | SynAct Pharma - Resomelagon progresses in RA, viral infections | 328 | SynAct Pharma has completed patient recruitment for its Phase IIb ADVANCE trial (n=240) in rheumatoid arthritis (RA), while initiating the Phase II RESPIRE study in hospitalised with respiratory insufficiency... ► Artikel lesen | ||
| 09.02. | Advanced Blockchain - Aspiring to become the gateway to digital assets | 544 | Advanced Blockchain (ABAG) is starting a new chapter following the appointment of new management in 2024 and the recent launch of its new strategy aimed at establishing a lean, resilient and transparent... ► Artikel lesen | ||
| 09.02. | Leading Edge Materials - Meeting Europe's rare earths challenge | 267 | Europe needs a long-term, secure source of rare earths and, increasingly, Greenland does not look like the answer. Rare earths are now clearly geopolitical, and, like the US, Europe will need 'in the... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.